weight loss drug news today glp-1 october 2025 obesity How Supply and Demand for Drugs is Playing Out in 2026 Older Americans Quit Weight Loss

For example, a client hit a 3-month stall post-GLP-1

02 Post-GLP-1 Aesthetic Spending: 11% increase in non-surgical treatments, with 62.4% of users seeking fixes for sagging

If testosterone, estrogen, or other sex hormones are suboptimal, addressing that imbalance through womens hormone therapy in Lexington, Louisville, and London or testosterone therapy for men in Kentucky can restore the hormonal foundation that supports healthy sexual function while the GLP-1 medication continues to do its work on the metabolic side

Yet, bridging the gap from lab to market was not straightforward

Among the GLP-1 RAs and a dual GLP-1/GIP RA, exenatide has the most developed pharmacokinetic model (9 of 30), 61,177184 followed by semaglutide (8 of 30), 68,162,182,185189 liraglutide and dulaglutide (each 5 of 30), 156,177,182,189194 and tirzepatide (3 of 30)

As the image below shows, fat consumption has steadily risen over the last century since we discovered how to extract oil from crops at scale, fuelled by synthetic fertilisers